DermTech’s Validation and Utility of a Non-Invasive 2-Gene Molecular Assay for Cutaneous Melanoma, has been accepted for oral presentation as a Late Breaking Abstract at the 74th Annual AAD Meeting in Washington, DC, March 4-8, 2016.
Please join us for Dr. Laura Ferris’ presentation, Saturday, March 5, 3:42 PM: Late-breaking Research Forums – Basic Science/Cutaneous Oncology/Pathology, Abstract Late-Breaking Abstract #3816